Absent Presences · an ethnographic study of the uncounted lives of people affected by leprosy in Latin America
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2020-08-01 → 2022-07-31
- EU contribution
- €174,806
- Participants
- 1
- Scheme
- MSCA-IF
Lines connect the coordinator with its partners.
Results in brief
Absent Presences: an ethnographic study of the uncounted lives of people affected by leprosy in Latin America
This MSC Action is titled “Absent Presences: an ethnographic study of the uncounted lives of people affected by leprosy in Latin America”. Its objectives were to explore: (1) the last decades’ official campaigns of the World Health Organization (WHO) to eliminate leprosy as a public health problem, (2) the impact of such campaigns on the lives of people already affected by this disease in Brazil, and (3) what has been rendered visible and invisible by the epidemiological data produced in this process. Since the introduction of Multidrug Therapy (MDT) in the 1980s, the number of cases of leprosy registered globally has decreased from over 5 million to about 200,000 cases. In 2000, WHO announced the achievement of the global elimination of leprosy as a public health problem (defined by a prevalence rate of less than one case per 10,000 persons). However, the exam of such an extraordinary decrease in cases is relevant for society because it was not purely due to a drop in transmission rates, but rather to an increase in under- and misdiagnosis—and, more importantly, due to a change in the way the number of cases was to be measured. As this MSC Action was able to outline, this process has given rise to new challenges such as the increase of foreign-born cases in the so-called Global North and the decrease in investment in the field of leprosy control. It called attention to the difficulties of getting local governments to invest in fresh research projects, campaigns of active surveillance, and relevant infrastructures in a context in which it is taken for granted that leprosy has been already eliminated as a global health problem. Drawing on literature from Science and Technology Studies, Medical Anthropology, and critical studies of global health, on the one hand, this project examined the production of statistical data, central to the evidence-making processes of the global epidemiological situation of leprosy. The project was able to demonstrate how the recommended measuring schemes for leprosy elimination created an ironic situation: while leprosy is perceived and often portrayed as a disease that no longer exists (a disease that was eliminated), many scientific, political, and medical questions regarding it remain unanswered and thousands of people continue getting diagnosed every year. On the other hand, the project focused on the past and present experiences of people affected by leprosy in Brazil. Based on interviews and ethnographic observations, the project was able to explore how the lives of these individuals have been affected by local health policies that came into place as recommended by the WHO. More specifically, it demonstrated how the declaration of the elimination of leprosy has been contributing to overlooking the long-term needs of patients in the so-called post-cure period.
Data: CORDIS, © European Union
Project objective
This research project focuses on the absent presences of people affected by leprosy in the World Health Organization’s (WHO) making of a leprosy-free world. In 2000, WHO announced the achievement of the global elimination of leprosy as a public health problem (defined by a prevalence rate of less than one case per 10,000 persons). Since the introduction of multidrug therapy (MDT) in the 1980s, the number of cases registered globally has decreased from over 5 million to about 200,000 cases. However, many scholars have suggested that such an extraordinary decrease is not due to a drop in transmission rates, but rather to an increase in misdiagnosed cases. They argue that the announcement of the global elimination of leprosy has caused the closing down of active surveillance campaigns as well as a progressive loss of expertise in diagnosis and treatment of leprosy. According to some estimates, between the years 2000 and 2020 as many as 4 million cases will be overlooked worldwide. This process has given rise to new challenges such as the increase of foreign-born cases in countries in the Global North. Drawing on literature from Science and Technology Studies (STS), medical anthropology and critical studies of global health, I propose to conduct a multi-sited ethnography focused on the uncounted lives of people affected by leprosy across borders in Latin America, examining WHO’s ongoing leprosy-free world project in specific settings. I argue that, in order to understand a possible drop in new cases and/or increase in under- and misdiagnosis, it is necessary to examine both local heterogenous elements and modifications in WHO’s global leprosy program. In particular, I will explore the modes of production of statistical data, central to evidence-making processes in the global epidemiological reality of leprosy.
Original text from CORDIS.
Participants
- FREIE UNIVERSITAET BERLIN · BerlinCoordinatorGermany
Links
- View on CORDIS
- DOI: 10.3030/886338
- https://www.polsoz.fu-berlin.de/en/ethnologie/forschung/arbeitsstellen/medical_anthropology/index.html
Data: CORDIS, © European Union
